Genetic ablation of TMEM106B expression was found to be effective in rescuing the FTD-like phenotypes in a transgenic mouse model carrying the GRN [218], but not the C9orf72, transgene [219]. The gene discussed is TMEM106B; the disease is frontotemporal dementia.